bluebird bio Inc
NASDAQ:BLUE
bluebird bio Inc
NASDAQ:BLUE
Price:
0.9164 USD
-3.28%
Market Closed
Updated:
Jun 6, 2024
bluebird bio Inc
PP&E Gross
|
bluebird bio Inc
PP&E Gross Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive PP&E Gross Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | PP&E Gross | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
bluebird bio Inc
NASDAQ:BLUE
|
PP&E Gross
$304.7m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
PP&E Gross
$5B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
9%
|
CAGR 10-Years
8%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
PP&E Gross
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Amgen Inc
NASDAQ:AMGN
|
PP&E Gross
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
PP&E Gross
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
PP&E Gross
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is bluebird bio Inc's PP&E Gross?
PP&E Gross
304.7m
USD
304.7m
USD
Based on the financial report for Sep 30, 2023, bluebird bio Inc's PP&E Gross amounts to 304.7m USD.
What is bluebird bio Inc's PP&E Gross growth rate?
PP&E Gross CAGR 5Y
6%
6%
Over the last year, the PP&E Gross growth was 1%. The average annual PP&E Gross growth rates for bluebird bio Inc have been -4% over the past three years , 6% over the past five years .
You don't have any saved screeners yet
